93201-2

LOINC code 93201-2 identifies "Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method". This test includes analysis of alleles at multiple genetic loci associated with coronary heart disease (CHD). Testing is performed to determine an individual's genetic-based risk for CHD, particularly in patients at intermediate risk for atherosclerotic cardiovascular disease (ASCVD) and those with family history of ASCVD. An overall genetic risk score (GRS) [LOINC: 93306-9] and interpretation (high/low) [LOINC: 93307-7] may be provided to improve risk estimates and aid in the prevention of CHD. The GRS is based on the genotype of multiple genetic variants associated with CHD. Additionally, a patient's overall 10-year probability of CHD may be calculated by multiply the 10-year ASCVD score from the Pooled Cohort Equations by the GRS.

This code measures Coronary heart disease multigene analysis in Bld/Tiss. It belongs to the MOLPATH class in the LOINC classification.

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.